Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Allergy Thera. (AGY) Share News

12345678910

Allergy Therapeutics' Hay Fever CTA Approved By Health Canada

19th Feb 2014 09:12

LONDON (Alliance News) - Allergy Therapeutics PLC said Wednesday that the Canadian health authority has approved its proposal to submit a full clinical trial application for an efficacy study for Pollinex Quattro Grass MATA MPL (0.5ml). The speciality pharma firm said its proposal for a new Read More

Allergy Therapeutics Says Positive Ragweed Allergy Treatment Published

27th Jan 2014 09:57

LONDON (Alliance News) - Allergy Therapeutics PLC said Monday that results from its Phase IIb clinical trial of its Pollinex Quattro ragweed allergy treatment have been published in the Journal of Allergy and Clinical Immunology. The trial showed that the treatment was safe and effective in Read More

Allergy Therapeutics Revenues Up 16%, Appoints New R&D Director

20th Nov 2013 10:05

Read More

AIM IN BRIEF: Rangers FC Appoints Graham Wallace As CEO

20th Nov 2013 07:52

Read More

Allergy Therapeutics Hit By Challenging Conditions As Profit Declines

16th Sep 2013 12:53

Read More

12345678910
FTSE 100 Latest
Value9,911.42
Change11.82